Remember, the stock started to tank during the time period running up to the supposed up listing. The stock gradually eroded but started to really crater after the uplist time period came and went. When the financiers realized that Amarantus had either no intentions of uplisting or didn't actually have in place the necessary financials to uplist, again not being truthful with those who lent it money, those financial entities then decdied to reap havoc on Gerald and the stock. That is where we are today. Gerald's false promises and empty rhetoric put the company right in the cross hairs of those who could take it down and they essentially have done so. The promise of partners, money, clinical trials all smoke. We really have no idea if the elto trials ever really started. Everything Gerald has said for years has been one big lie. He is saved by the fact the company is on the OTC but I think the time is ripe to start a class action lawsuit. He has burned a lot of people.
(3)
(2)
Amarantus Bioscience Holdings (AMBS) Stock Research Links